Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma

Author(s): Salah Almokadem

Journal Name: Current Molecular Pharmacology

Volume 9 , Issue 3 , 2016

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Squamous cell carcinoma of the mucosal surfaces of the head and neck area exhibits a complex interaction with the host immune system that plays an important part in the evolution of the malignant process, in the resistance to different therapeutic modalities, and the ability of tumor cells to metastasize to distant organs. The recent advances in tumor immunology have transformed the field in onco-immunology from using non-specific immune-stimulant agents such as interferon and interleukins to the area of rationally targeted immunotherapy such as immune checkpoint inhibitors, which have shown promising results in early phase clinical trials.

Keywords: Checkpoint inhibitors, cytokines, HNSCC, immune system, immunotherapy, PD-1.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 04 September, 2016
Page: [226 - 230]
Pages: 5
DOI: 10.2174/1874467208666150716120658
Price: $65

Article Metrics

PDF: 22